DPP4 and congenital bilateral aplasia of vas deferens from CFTR mutation: The underlying mechanisms of DPP-4 inhibitors on retarding CAVD might be alleviating inflammation, fibrosis, and calcification (Choi et al., 2017; Lee et al., 2020; Choi et al., 2021).